ICER CTAF Public Meeting on Myelodysplastic Syndrome: Voting Session

(54:54)

ICER CTAF Public Meeting on Metachromatic Leukodystrophy: Evidence Presentation

(1:34:59)

ICER CTAF Public Meeting on Sickle Cell Disease (SCD): Policy Roundtable

(1:49:6)

ICER CTAF Public Meeting on Sickle Cell Disease (SCD): Evidence Summary

(1:44:53)

ICER CTAF Public Meeting on Myelodysplastic Syndrome: Evidence Presentation

(1:41:4)

ICER CTAF Public Meeting on Early Alzheimer's Disease: Public Comment

(32:58)

ICER CTAF Public Meeting on Mavacamten for Hypertrophic Cardiomyopathy - Evidence Presentation

(1:45:31)

ICER CTAF Public Meeting on Hemophilia A \u0026 B: Evidence Presentation

(1:34:44)

ICER CTAF Public Meeting on Early Alzheimer's Disease: Evidence Presentation

(1:45:2)

ICER CTAF Public Meeting on Paroxysmal Nocturnal Hemoglobinuria: Evidence Presentation

(1:36:47)

ICER CTAF Public Meeting on Mavacamten for Hypertrophic Cardiomyopathy - Voting Session

(52:15)

ICER CTAF Public Meeting on Paroxysmal Nocturnal Hemoglobinuria: Public Comments

(23:10)

ICER CTAF Public Meeting on Hemophilia A \u0026 B: Policy Roundtable

(1:45:19)

ICER CTAF Public Meeting on Metachromatic Leukodystrophy: Public Comment

(33:44)

ICER CTAF Public Meeting on Mavacamten for Hypertrophic Cardiomyopathy - Policy Roundtable

(1:51:)

ICER CTAF Public Meeting on Sickle Cell Disease (SCD): Public Comments

(44:40)

ICER CTAF Public Meeting on Metachromatic Leukodystrophy: Policy Roundtable

(1:36:37)

ICER CTAF Public Meeting on Myelodysplastic Syndrome: Oral Comments

(22:54)

ICER CTAF Public Meeting on Myelodysplastic Syndrome: Policy Roundtable

(3:9:48)

ICER CTAF Public Meeting on Mavacamten for Hypertrophic Cardiomyopathy - Public Comments

(39:17)